Diabetes Channel
Related Channels

Avandia and Heart Attacks

A recent study has suggested that people taking Avandia were 43 percent more likely to have a heart attack, compared to people taking other diabetes drugs or a sugar pill. However, this study was a compilation of several small studies and when this is done, even a small difference can seem large. Avandia may increase the risk of heart attacks because it can increase cholesterol and cause weight gain. However, more research is needed to fully understand the risks associated with Avandia. Until then, do not stop taking Avandia without first discussing it with your healthcare provider.

An Overview of Avandia and Heart Attacks

A recent study suggested that Avandia® (rosiglitazone maleate) may increase the risk of heart attacks. Avandia is a prescription medication used to treat type 2 diabetes. It is part of a group of diabetes medications called thiazolidinediones (or sometimes called "glitazones").
In September 2010, the U.S. Food and Drug Administration (FDA) announced that it was severely restricting the use of Avandia, due to the risk of "cardiovascular events" such as heart attacks and strokes. Only individuals who could not control their diabetes on other medications (or those who were already taking the medication and doing well) would be able to take Avandia.
However, in November 2013, the FDA announced that a careful analysis of the research suggests that there is not, in fact, any increased risk, compared to treatment with standard diabetes medications and that the use of this medication will no longer be restricted.
Ouch! 6 Types of Pain You Might Experience When Getting a Stent

Avandia Medication

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.